These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2259752)

  • 21. Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.
    Horiuchi K; Ohnishi S; Matsuzaki T; Funaki S; Watanabe A; Mizutare T; Matsumoto S; Nezasa KI; Hasegawa H
    J Pharm Sci; 2018 May; 107(5):1443-1453. PubMed ID: 29331382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
    Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL
    J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interspecies extrapolation in safety evaluation of human medicines in The Netherlands (1990-1992): practical considerations.
    Peters-Volleberg GW; De Waal EJ; Van der Laan JW
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):248-58. PubMed ID: 7724833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways.
    Frederick CB; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):211-31. PubMed ID: 9772217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment.
    Kedderis GL; Lipscomb JC
    Toxicol Ind Health; 2001 Jun; 17(5-10):315-21. PubMed ID: 12539878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translating dosages from animal models to human clinical trials--revisiting body surface area scaling.
    Blanchard OL; Smoliga JM
    FASEB J; 2015 May; 29(5):1629-34. PubMed ID: 25657112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating in vitro ADMET data through generic physiologically based pharmacokinetic models.
    Leahy DE
    Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):619-28. PubMed ID: 16859409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to Humans.
    Bi Y; Deng J; Murry DJ; An G
    AAPS J; 2016 Jan; 18(1):228-38. PubMed ID: 26559435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans.
    Luttringer O; Theil FP; Poulin P; Schmitt-Hoffmann AH; Guentert TW; Lavé T
    J Pharm Sci; 2003 Oct; 92(10):1990-2007. PubMed ID: 14502539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
    Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
    J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models.
    Dallmann A; Pfister M; van den Anker J; Eissing T
    Clin Pharmacol Ther; 2018 Dec; 104(6):1110-1124. PubMed ID: 29633257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of interspecies risk comparisons.
    Brown SL; Brett SM; Gough M; Rodricks JV; Tardiff RG; Turnbull D
    Regul Toxicol Pharmacol; 1988 Jun; 8(2):191-206. PubMed ID: 3051142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicokinetic modeling and its applications in chemical risk assessment.
    Andersen ME
    Toxicol Lett; 2003 Feb; 138(1-2):9-27. PubMed ID: 12559690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposure.
    Frederick CB; Gentry PR; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
    Inhal Toxicol; 2001 May; 13(5):359-76. PubMed ID: 11295868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmacokinetics of organic chemicals.
    Béliveau M; Lipscomb J; Tardif R; Krishnan K
    Chem Res Toxicol; 2005 Mar; 18(3):475-85. PubMed ID: 15777087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.
    Lin Z; Monteiro-Riviere NA; Kannan R; Riviere JE
    Nanomedicine (Lond); 2016 Jan; 11(2):107-19. PubMed ID: 26653715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.